Allogene Therapeutics (ALLO) null Earnings

8MarConfirmed
Oct 18
Mar 19
-10.71
-7.23
-3.74
-0.26

Details

Expected EPS
-0.26
Actual EPS
-0.37
Surprise EPS
-0.11
Surprise Percent
+42.31%

Description

Allogene Therapeutics (ALLO) has reported earnings of -0.37 per share for .

0 Comments

Share your thoughts